Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
535.29
+10.77 (2.05%)
Oct 22, 2026, 4:00 PM EDT - Market closed
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of $135.68 billion as of October 22, 2026. It is the 161st most valuable company in the world and the 92nd biggest in the United States. Its market cap has increased by 24.14% in one year.
Market Cap
135.68B
Enterprise Value
124.01B
1-Year Change
24.14%
Global Rank
Country Rank
#92 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $135.68B, an increase of 22,087.26%. That is a compound annual growth rate of 21.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 135.68B | 17.95% |
| Dec 31, 2025 | 115.03B | 10.91% |
| Dec 31, 2024 | 103.71B | -1.09% |
| Dec 29, 2023 | 104.85B | 41.44% |
| Dec 30, 2022 | 74.13B | 32.76% |
| Dec 31, 2021 | 55.83B | -9.15% |
| Dec 31, 2020 | 61.46B | 9.15% |
| Dec 31, 2019 | 56.30B | 32.95% |
| Dec 31, 2018 | 42.35B | 11.74% |
| Dec 29, 2017 | 37.90B | 107.41% |
| Dec 30, 2016 | 18.27B | -40.90% |
| Dec 31, 2015 | 30.92B | 8.21% |
| Dec 31, 2014 | 28.57B | 64.52% |
| Dec 31, 2013 | 17.37B | 91.17% |
| Dec 31, 2012 | 9.09B | 31.16% |
| Dec 30, 2011 | 6.93B | -2.69% |
| Dec 31, 2010 | 7.12B | -8.32% |
| Dec 31, 2009 | 7.76B | 69.85% |
| Dec 31, 2008 | 4.57B | 48.74% |
| Dec 31, 2007 | 3.07B | -34.61% |
| Dec 29, 2006 | 4.70B | 71.34% |
| Dec 30, 2005 | 2.74B | 223.10% |
| Dec 31, 2004 | 848.90M | 5.56% |
| Dec 31, 2003 | 804.20M | -33.56% |
| Dec 31, 2002 | 1.21B | -34.33% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moderna | 96.67B |
| Regeneron Pharmaceuticals | 80.63B |
| argenx SE | 57.75B |
| BeOne Medicines AG | 43.72B |
| Revolution Medicines | 42.13B |
| Royalty Pharma | 35.79B |
| Alnylam Pharmaceuticals | 30.87B |
| Roivant Sciences | 25.22B |